All adults diagnosed with rheumatoid arthritis (RA) should have a blood test for anti-cyclic citrullinated peptide (anti-CCP) antibodies to identify those at higher risk for more severe disease and who… Click to show full abstract
All adults diagnosed with rheumatoid arthritis (RA) should have a blood test for anti-cyclic citrullinated peptide (anti-CCP) antibodies to identify those at higher risk for more severe disease and who need active monitoring, says draft guidance from the National Institute for Health and Care Excellence (NICE).1 The guideline strengthens previous advice on anti-CCP antibody testing by recommending measuring levels in all patients as soon as possible after diagnosing RA. It is based on …
               
Click one of the above tabs to view related content.